Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Will Be the Growth Trajectory of the Ankylosing Spondylitis Market from 2024 to 2033?
In the recent past, there has been impressive growth in the ankylosing spondylitis market. It’s projected to surge from $5.41 billion in 2023 to an estimated $5.86 billion in 2024, marking a compound annual growth rate (CAGR) of 8.4%. This remarkable growth in the historic period is the result of factors like the discovery of hla-b27, advancements in biologic treatments, improvements in pain management strategies, patient advocacy and increased awareness, the use of NSAIDs, and the introduction of disease modifying drugs.
We anticipate a robust expansion in the ankylosing spondylitis market in the upcoming years. The market is projected to rise to $7.89 billion by 2028, with a compound annual growth rate (CAGR) of 7.7%. This expansion throughout the projection duration can be credited to approaches like personalized medicine, development of innovative biologics, early intervention and screening, lifestyle and diet adjustments, and the utilization of telemedicine and remote monitoring. Noteworthy trends predicted during this period include the availability of biosimilars, focused pain therapies, an emphasis on patient-reported outcomes (pros), community aid programs, and investigation into regenerative medicine.
Claim Your Free Sample of the Global Ankylosing Spondylitis Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp
What Are the Primary Growth Drivers for the ankylosing spondylitis Market?
The growth of the ankylosing spondylitis market is projected to be fueled by the expanding elderly population. The term “geriatric population” pertains to a growth in the percentage of older individuals as a result of demographic changes. This modification in demographic structure has led to a rise in both the quantity and ratio of individuals who are 60 years or older. Treatments and medications for ankylosing spondylitis serve to enhance the range of movement and control pain among the elderly diagnosed with this condition. For example, the World Health Organization, a public health organization based in Switzerland, reported in October 2022 that by 2030, one in six individuals across the globe would be over the age of 60. Moreover, in 2020, the number of aged people surged from one billion to 1.4 billion. Consequently, the rising geriatric population is a driving factor for the ankylosing spondylitis market’s expansion.
What Are the Defining Segments of the Ankylosing Spondylitis Market?
1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users
What Trends Are Revolutionizing Standards in the Ankylosing Spondylitis Market?
The development of new treatment alternatives is a rising trend influencing the ankylosing spondylitis market sector. A key strategy for businesses in the ankylosing spondylitis field is the introduction of innovative therapeutic solutions to maintain market dominance. In a pertinent example from December 2021, Pfizer Inc., a pharmaceutical and biotech organization based in the U.S, gained FDA approval for its medication XELJANZ (tofacitinib), intended for the management of active ankylosing spondylitis. As a Janus kinase (JAK) inhibitor, XELJANZ (tofacitinib) successfully treats five different immuno-inflammatory illnesses and is a potent alternative for those who have shown intolerance or inadequate responses to one or more tumor necrosis factor (TNF) blockers. Notably, this medication is not dependent on injections or infusions for administration.
Order Now for Fast Delivery of Your Ankylosing Spondylitis Market Report!
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report
What Regions Are Propelling Growth in the Ankylosing Spondylitis Industry?
North America was the largest region in the ankylosing spondylitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Ankylosing Spondylitis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ankylosing spondylitis market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Ankylosing Spondylitis Market Include
1. Ankylosing Spondylitis Market Executive Summary
2. Ankylosing Spondylitis Market Segments
3. Ankylosing Spondylitis Market Size And Template Market Growth Rate
4. Key Ankylosing Spondylitis Market Trends
5. Major Ankylosing Spondylitis Market Drivers
……
25. Key Mergers And Acquisitions In The Ankylosing Spondylitis Market
26. Top Ankylosing Spondylitis Companies
27. Ankylosing Spondylitis Market Opportunities And Strategies
28. Ankylosing Spondylitis Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
